Press Releases May 11, 2026 04:05 PM

Amwell® to Participate in Upcoming Investor Conference

Amwell to present at 21st Annual Needham Technology, Media & Consumer Conference

By Hana Yamamoto
Share
Twitter Reddit Facebook LinkedIn
AMWL

Amwell announced that CFO and COO Mark Hirschhorn will participate in a virtual presentation at the upcoming Needham Technology, Media & Consumer Conference on May 14, showcasing the company's SaaS-based healthcare platform.

Amwell® to Participate in Upcoming Investor Conference
AMWL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Amwell is a leading provider of SaaS-based technology-enabled healthcare platforms.
  • The company serves major healthcare organizations in the US and internationally with integrated clinical program solutions.
  • Participation in the Needham conference provides a platform to highlight Amwell's technology and growth strategy to investors.

BOSTON, May 11, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced that Mark Hirschhorn, CFO and COO, will participate in the 21st Annual Needham Technology, Media & Consumer Conference, taking place virtually on May 14, including a presentation at 2:15 p.m. ET. An audio webcast of the fireside chat will be available at investors.amwell.com.

About Amwell

Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.

Contacts

Media:
[email protected]

Investors:
Asher Dewhurst
[email protected] 


Risks

  • Market competition in the digital health technology sector remains intense, potentially impacting growth.
  • Dependence on adoption of telehealth and SaaS platforms by healthcare providers could affect future revenue.
  • Regulatory changes in healthcare and telemedicine could introduce operational challenges.

More from Press Releases

Space Exploration Technologies Corporation to Join the Nasdaq-100 Index® Beginning July 7, 2026 Jun 26, 2026 XMax Announces Up to Approximately US$25 million in AI API-Related Service Contracts and Expansion into GPU-as-a-Service Jun 26, 2026 Cartesian Growth Corporation IV Announces Closing of $275 Million Initial Public Offering Jun 26, 2026 dLocal added to membership of US small-cap Russell 2000® Index Jun 26, 2026 Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance Jun 26, 2026